|
Volumn 84, Issue 2, 2004, Pages 120-123
|
Skin Reaction in Antiviral Therapy for Chronic Hepatitis C: A Role for Polyethylene Glycol Interferon?
|
Author keywords
Antiviral therapy; HCV; PEG interferon; Skin reaction
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
AMANTADINE;
ANTIVIRUS AGENT;
CD4 ANTIGEN;
CORTICOSTEROID;
INTERFERON;
MACROGOL;
PEGINTERFERON;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
PREDNISONE;
RIBAVIRIN;
VIRUS RNA;
ANTIVIRAL ACTIVITY;
ARTICLE;
ASTHENIA;
BLOOD DISEASE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
DERMATITIS;
DESQUAMATION;
DISEASE SEVERITY;
DRUG CONJUGATION;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG SCREENING;
DRUG WITHDRAWAL;
DRY SKIN;
ECZEMA;
ERYTHEMA;
FATIGUE;
FLU LIKE SYNDROME;
HEPATITIS C;
HERPES ZOSTER;
HISTOPATHOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
INJECTION SITE;
LICHEN PLANUS;
LICHENOID ERUPTION;
LIVER BIOPSY;
LYMPHOCYTIC INFILTRATION;
MENTAL DISEASE;
MONOTHERAPY;
NEUROLOGIC DISEASE;
OUTCOMES RESEARCH;
PAPULE;
PHARMACOKINETICS;
PRIORITY JOURNAL;
PRURIGO;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SEBORRHEIC DERMATITIS;
SKIN BIOPSY;
SKIN DISEASE;
SKIN MANIFESTATION;
ADULT;
AMANTADINE;
ANTIVIRAL AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG ERUPTIONS;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON ALFA-2B;
MALE;
MIDDLE AGED;
POLYETHYLENE GLYCOLS;
RIBAVIRIN;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SOLVENTS;
TREATMENT OUTCOME;
|
EID: 11144358155
PISSN: 00015555
EISSN: None
Source Type: Journal
DOI: 10.1080/00015550310007085 Document Type: Article |
Times cited : (20)
|
References (13)
|